2022
DOI: 10.1136/bmjopen-2021-052432
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: a mixed-method study

Abstract: ObjectiveData on COVID-19 vaccine hesitancy is limited in Ethiopia and other parts of Africa. Therefore, the aim of this study was to determine the level of COVID-19 vaccine hesitancy and its associated factors in Addis Ababa, Ethiopia.DesignA community-based concurrent mixed-method study.SettingIn a community setting.ParticipantsAdult residents (n=422) of Akaki Kality subcity who were recruited by a two stage sampling technique and 24 adults who were selected purposively were included for the quantitative and… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

9
39
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 64 publications
(49 citation statements)
references
References 21 publications
9
39
1
Order By: Relevance
“…The data was collected using a structured questionnaire adapted from previous published papers [23][24][25][26][27]29,30,34,[37][38][39][40][41] and contextualized according to the study setting. The questionnaire consists of socio-demographic characteristics of the participants, socio-political perception and attitude towards COVID-19 vaccine, and willingness towards the acceptance of COVID-19 vaccine.…”
Section: Data Collection and Quality Assurancesmentioning
confidence: 99%
See 1 more Smart Citation
“…The data was collected using a structured questionnaire adapted from previous published papers [23][24][25][26][27]29,30,34,[37][38][39][40][41] and contextualized according to the study setting. The questionnaire consists of socio-demographic characteristics of the participants, socio-political perception and attitude towards COVID-19 vaccine, and willingness towards the acceptance of COVID-19 vaccine.…”
Section: Data Collection and Quality Assurancesmentioning
confidence: 99%
“…1,21 Many Ethiopians are reluctant to receive the COVID-19 vaccine. [24][25][26][27]29,30 Forty eight percent of the study populations are unsure about the COVID-19 vaccines, according to a global assessment of possible COVID-19 vaccine approval. 5 Consequently, in May 2020, the 73rd World Health Assembly passed a resolution endorsing broad immunization as a global public health objective for halting the spread of SARS-CoV-2.…”
Section: Introductionmentioning
confidence: 99%
“… 26 According to different studies conducted in Ethiopia, the COVID-19 vaccine hesitancy level in the Ethiopian population ranged from 14.1% to 68.7%. 27 , 28 As of September 27, 2022, 12.71 billion, over 1.4 billion, and over 95 million doses of COVID-19 vaccine (AstraZeneca, Sinopharm, Johnson and Johnson, or Pfizer) had been administered globally, in Africa, and in Ethiopia, respectively. From this figure nearly 44.5% have received at least one dose, and 30.5% had been fully vaccinated.…”
Section: Introductionmentioning
confidence: 99%
“…Myths and misconceptions around the COVID 19 vaccine subject have been circulating and its impact can be observed especially in developing countries [1]. This has been shown to contribute to the observed vaccine hesitancy, which is defined by WHO as the reluctance in accepting vaccines or an outright refusal of vaccines despite their availability [7].…”
Section: Introductionmentioning
confidence: 99%
“…The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome corona virus 2 (SARs-CoV-2) remains a significant disease of public health concern. Since its emergence, it has been shown to spread rapidly causing dramatic global health crisis [1] . It was declared as a pandemic by the World Health Organization (WHO) on the 11th of March 2020, with a total of 56,837,067 confirmed cases, 340,447 new cases and 928,593 confirmed deaths globally as of January 17, 2022 [2].…”
Section: Introductionmentioning
confidence: 99%